WHAT ARE YOU LOOKING FOR?
Phosphatidylglycerol (PG) phospholipids carry a negative charge due to their negatively charged polar phosphate groups, rendering the entire molecule negatively charged. Depending on the fatty acid chains, common PG phospholipids such as dipalmitoylphosphatidylglycerol (DPPG) and dimyristoylphosphatidylglycerol (DMPG) show significant differences in phase transition temperatures.
| Product name | DMPG |
| Chemical name | |
| Molecular formula | |
| CAS No. | 67232-80-8 |
| CDE Record registration Number | |
| FDA DMF Number | |
| Grade | |
| Quality standards | |
| Sufficient supply, cost-effective | |
| Description | |
| Applications | |
| Product Code | S02002 |
| Available Package Sizes |
Phosphatidylglycerol (PG) phospholipids are widely used in preparation of liposomes;
Lipid particles with negative charges can prevent particle aggregation, thereby enhancing the stability of formulations;
Negatively charged lipid particles are more likely to penetrate cell membranes for delivery.
Lipid particles with negative charges can deliver anti-cancer drugs across cell membranes and even nuclear membranes into cancer cells, thus effectively killing cancer cells. It is of significant importance for cancer treatment. However, the purpose of using PG phospholipids in products such as the Amphotericin B Liposome for Injection (Ambisome) and the Bupivacaine Liposome Injection is to prevent phospholipid membrane fusion and particle aggregation, thereby enhancing formulation stability.
If you have any questions, please don't hesitate to contact us. We're always here to help with Pharmaceutical Excipients for your business. We can provide products ranging from grams to tons. AVT is able to produce and even register the product in US FDA according to your special needs.
